In an interoffice memo from Amour, Dr Christie stated that they had a meeting with the DHSS and that there was no evidence that the DHSS regarded Armour products and their current heat treatment method as unsatisfactory and no indication that the DHSS wished for them to withdraw batches of product from unscreened donor pools.
Chronology Information
Date:
Chapter/issue
Blood Products and Addressing Risk: Viral Inactivation
Key Person(s)
Dr Frances Rotblat
Dr Peter A Harris
Robert B Christie